The content is available as a PDF (377.5 KB).
References
- 1.Pearce JM. Bromide, the first effective antiepileptic agent. J Neurol Neurosurg Psychiatry. 2002;72:412–412. doi: 10.1136/jnnp.72.3.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology. 2002;58(8):S2–S8. doi: 10.1212/wnl.58.8_suppl_5.s2. [DOI] [PubMed] [Google Scholar]
- 3.Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev. 2007;17:413–425. doi: 10.1007/s11065-007-9043-9. [DOI] [PubMed] [Google Scholar]
- 4.Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res. 2002;50:3–16. doi: 10.1016/S0920-1211(02)00063-3. [DOI] [PubMed] [Google Scholar]
- 5.Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res. 2004;60:77–159. doi: 10.1016/j.eplepsyres.2004.06.004. [DOI] [PubMed] [Google Scholar]
- 6.Löscher W, Schmidt D. New Horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res. 2006;69:183–272. doi: 10.1016/j.eplepsyres.2006.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dichter MA. Innovative clinical trial designs for future antiepileptic drugs. Epilepsia. 2007;48(Suppl 1):26–30. doi: 10.1111/j.1528-1167.2007.00996.x. [DOI] [PubMed] [Google Scholar]
- 8.Rosenow J, Das K, Rovit RL, Couldwell WT, Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg. 2002;78:95–112. doi: 10.1159/000068011. [DOI] [PubMed] [Google Scholar]
- 9.Löscher W, Gemert M, Heinemann U. Cell and gene therapies in epilepsy—promising avenues or blind alleys? Trends Neurosci. 2008;31:62–73. doi: 10.1016/j.tins.2007.11.012. [DOI] [PubMed] [Google Scholar]